A Multi-center, Double Blind, Randomized, Placebo Controlled Study of Testogel (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism

Trial Profile

A Multi-center, Double Blind, Randomized, Placebo Controlled Study of Testogel (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Biomarker; Registrational; Therapeutic Use
  • Most Recent Events

    • 13 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top